| __timestamp | Celldex Therapeutics, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 10811000 |
| Thursday, January 1, 2015 | 33837000 | 33001000 |
| Friday, January 1, 2016 | 35979000 | 64936000 |
| Sunday, January 1, 2017 | 25003000 | 99909000 |
| Monday, January 1, 2018 | 19269000 | 127724000 |
| Tuesday, January 1, 2019 | 15426000 | 161524000 |
| Wednesday, January 1, 2020 | 14456000 | 182933000 |
| Friday, January 1, 2021 | 20488000 | 219982000 |
| Saturday, January 1, 2022 | 27195000 | 278139000 |
| Sunday, January 1, 2023 | 30914000 | 309799000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Ultragenyx Pharmaceutical Inc. and Celldex Therapeutics, Inc. from 2014 to 2023. Over this period, Ultragenyx has seen a staggering increase in SG&A expenses, growing nearly 2,800% from 2014 to 2023. In contrast, Celldex's expenses have fluctuated, peaking in 2016 and then stabilizing. By 2023, Ultragenyx's SG&A expenses were approximately ten times higher than Celldex's, highlighting its aggressive expansion strategy. This trend underscores the differing approaches of these companies in navigating the biotech landscape. As Ultragenyx invests heavily in administrative and sales functions, Celldex appears to be more conservative, potentially focusing on other areas of growth. Understanding these financial strategies provides valuable insights into their market positioning and future prospects.
Johnson & Johnson or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
AstraZeneca PLC and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Ultragenyx Pharmaceutical Inc.
Insmed Incorporated vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Walgreens Boots Alliance, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Corcept Therapeutics Incorporated vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Cytokinetics, Incorporated vs Ultragenyx Pharmaceutical Inc.
TG Therapeutics, Inc. and Ultragenyx Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Ultragenyx Pharmaceutical Inc. and MorphoSys AG
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Protagonist Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Perrigo Company plc vs Celldex Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Galapagos NV vs Celldex Therapeutics, Inc.